Forced degradation studies of a new antileishmanial molecules using a stability-indicating RP-HPLC method

ABSTRACT: A stability indicating RP-HPLC method was developed and validated to study the forced stability of a quinoline-triclosan hybrid, a new agent (Quinoline-triclosan hybrid) for cutaneous Leishmaniasis treatment. The method was developed using a C18 column (250 mm x 4.6 mm, 5 μm) and acetonitr...

Full description

Autores:

Gallardo Cabrera, Cecilia
Enríquez Benavides, Iván Santiago
Pazmino Arteaga, Jhonathan David
Cardona Galeano, Wilson
Robledo Restrepo, Sara María

Tipo de recurso:

Article of investigation

Fecha de publicación:

2015

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/35891

Acceso en línea:

https://hdl.handle.net/10495/35891
https://www.jocpr.com/archive/jocpr-volume-7-issue-5-year-2015.html

Palabra clave:

Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Imiquimod
Triclosán
Vacunas contra la Leishmaniasis
Leishmaniasis Vaccines
Estabilidad de Medicamentos
Drug Stability

Rights

openAccess

License

https://creativecommons.org/licenses/by-nc-nd/4.0/